Jung Cassie (CIK 1960154) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-07). Recent activity: Sell AQST (72,734 shares), Buy AQST (80,000 shares), Sell AQST (45,791 shares), Buy AQST (25,000 shares), Sell AQST (67,575 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 72,734 | $304,028 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Buy | 80,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 45,791 | $190,948 |
| 2025-10-17 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Buy | 25,000 | $77,500 |
| 2025-10-17 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 67,575 | $473,701 |
| 2025-09-08 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Buy | 25,000 | $78,750 |
| 2025-09-08 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Buy | 25,000 | $17,750 |
| 2025-09-08 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 62,180 | $310,900 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Buy | 80,000 | $0 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 7,361 | $19,507 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 7,997 | $21,192 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | Sell | 2,182 | $5,542 |
Source: SEC Form 4 filings · as of 2026-05-07